Agenus Inc. , a leader in immuno-oncology, today shared new data on botensilimab (BOT) and balstilimab (BAL) at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) ...
Traditionally carrying a dire prognosis, the treatment paradigm for multiple myeloma is changing, with CAR T therapies, ...
Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a ...
Nurix Therapeutics (NRIX) leads in targeted protein modulation with its DELigase platform, developing BTK degraders like ...
The company's current portfolio consists of its proprietary cell and gene therapy programs using DNA and RNA as therapeutics and genomics-based diagnostics. Other assets include clinical-stage ...
Bangladesh Rewriting Textbooks on 1971 War: The Bangladesh interim government has revised textbooks on the 1971 Liberation War to state that Ziaur Rahman declared the country’s independence, replacing ...
Chairman of the National Curriculum and Textbook Board (NCTB), AKM Riazul Hasan, said that a total of 441 primary and secondary textbooks have been revised, and they are now available on the NCTB ...
"We found that on average, older adults who are immunocompromised developed fewer antibodies against RSV following vaccination as compared with the very strong responses for healthy people over ...
“We found that on average, older adults who are immunocompromised developed fewer antibodies against RSV following vaccination as compared with the very strong responses for healthy people over age 60 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback